- Home
- BARK vs OBIO Comparison
BARK vs OBIO Comparison
Compare BARK & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BARK
- OBIO
- Stock Information
- Founded
- BARK 2011
- OBIO 2017
- Country
- BARK United States
- OBIO United States
- Employees
- BARK N/A
- OBIO N/A
- Industry
- BARK Department/Specialty Retail Stores
- OBIO Medicinal Chemicals and Botanical Products
- Sector
- BARK Consumer Discretionary
- OBIO Health Care
- Exchange
- BARK Nasdaq
- OBIO Nasdaq
- Market Cap
- BARK 146.0M
- OBIO 172.1M
- IPO Year
- BARK N/A
- OBIO N/A
- Fundamental
- Price
- BARK $0.74
- OBIO $3.93
- Analyst Decision
- BARK Strong Buy
- OBIO Strong Buy
- Analyst Count
- BARK 3
- OBIO 4
- Target Price
- BARK $2.50
- OBIO $13.67
- AVG Volume (30 Days)
- BARK 1.1M
- OBIO 303.3K
- Earning Date
- BARK 11-10-2025
- OBIO 11-10-2025
- Dividend Yield
- BARK N/A
- OBIO N/A
- EPS Growth
- BARK N/A
- OBIO N/A
- EPS
- BARK N/A
- OBIO N/A
- Revenue
- BARK $451,690,000.00
- OBIO $2,818,000.00
- Revenue This Year
- BARK N/A
- OBIO $31.43
- Revenue Next Year
- BARK $6.25
- OBIO $10.87
- P/E Ratio
- BARK N/A
- OBIO N/A
- Revenue Growth
- BARK N/A
- OBIO 6.46
- 52 Week Low
- BARK $0.73
- OBIO $2.20
- 52 Week High
- BARK $2.56
- OBIO $6.50
- Technical
- Relative Strength Index (RSI)
- BARK 37.72
- OBIO 55.58
- Support Level
- BARK $0.74
- OBIO $3.72
- Resistance Level
- BARK $0.84
- OBIO $4.02
- Average True Range (ATR)
- BARK 0.07
- OBIO 0.31
- MACD
- BARK -0.01
- OBIO -0.02
- Stochastic Oscillator
- BARK 2.79
- OBIO 45.59
About BARK BARK Inc.
BARK Inc is a vertically integrated, omnichannel brand serving dogs across two key categories: toys & accessories and consumables. It serves dogs nationwide with monthly subscription services, BarkBox and Super Chewer; e-commerce experience on BarkShop.com; custom collections via its retail partner network, including Target and Amazon; wellness products that meet dogs' needs with BARK Bright; and a personalized meal delivery service for dogs BARK Eats. The company's reportable segments are; Direct to Consumer (D2C), and Commerce. The majority of its revenue is generated from the Direct to Consumer segment which derives revenue from the sale of toys & accessories and consumables through BarkBox, Super Chewer, and the company's consumables website.
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.